SC
CL icon

SummitTX Capital’s Colgate-Palmolive CL Stock Holding History

SummitTX Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.53M Buy
+76,563
New +$6.82M 0.2% 125
2025
Q3 		– Sell
-7,544
Closed -$686K – 788
2025
Q2 		$686K Buy
+7,544
New +$689K 0.03% 445

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SummitTX Capital's CL Position: Q1 2026 in Review

SummitTX Capital opened a new position in Colgate-Palmolive (CL) in Q1 2026: 76,563 shares worth $6.53M. The stake represents 0.2% of the portfolio and ranks #125 among its holdings. This is a return to the name: SummitTX Capital previously reported a position in CL as recently as Q2 2025.

SummitTX Capital first reported a position in CL in Q2 2025 and has held it in 2 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • SummitTX Capital held 76,563 shares of Colgate-Palmolive worth $6.53M as of Q1 2026.
  • Colgate-Palmolive was a new SummitTX Capital position in Q1 2026.
  • Colgate-Palmolive made up 0.2% of SummitTX Capital's portfolio in Q1 2026, its #125 holding.
  • SummitTX Capital first reported a position in Colgate-Palmolive in Q2 2025 and has held it in 2 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.